Telcadin 80 mg (Telmisartan)

Adult dose

1. Essential Hypertension The recommended starting dose is 40 mg of Telmisartan taken orally once daily with water, regardless of meals. A dose of 20 mg once daily may be effective for some patients, and if necessary, the dose may be increased up to 80 mg once daily. The maximum antihypertensive effect occurs 4 to 8 weeks after initiating treatment. 2. Reduction of Risk of Cardiovascular Disease For this purpose, it is recommended to take 80 mg once daily with water, regardless of meals. The effects of doses below 80 mg on morbidity and mortality from cardiovascular disease are not known. When starting therapy with this drug for the purpose of reducing cardiovascular risk, monitoring of blood pressure is recommended, and appropriate adjustments of antihypertensives may be required. ○ Patients with Liver Impairment Patients with mild to moderate liver impairment should be treated with caution and should not exceed a dose of 40 mg once daily.

This drug can cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be used in individuals who are allergic to this medication, pregnant or breastfeeding women, patients with severe liver impairment, those with a history of certain types of angioedema, and patients with diabetes or severe renal impairment. Particular caution should be exercised in elderly patients and those with high serum potassium levels, weakened liver function, or heart or kidney disease. Rare side effects may include cough, dizziness, headache, abdominal pain, muscle pain, and skin rash; in serious cases, angioedema or renal dysfunction may occur, so if any unusual symptoms appear, immediate consultation with medical personnel is necessary. Particularly, blood pressure may drop sharply resulting in dizziness or fainting, so careful observation of the condition is required in the early stages of treatment. This drug may interact when taken with other antihypertensive medications, so if any other medications are being taken, be sure to inform the doctor; when used with lithium or certain diuretics, non-steroidal anti-inflammatory drugs, etc., blood pressure, renal function, and serum electrolyte levels should be monitored frequently. This medication should not be taken during pregnancy, and it is recommended to avoid taking it while breastfeeding or to stop breastfeeding. The safety and efficacy of this drug have not been established in children under 18 years of age, so it is not recommended for them. In case of overdose, symptoms such as hypotension, dizziness, or acute renal failure may appear, and one should seek medical attention immediately if suspected, with treatment conducted as necessary based on symptoms. Store in a place out of reach of children, and since the tablets are sensitive to moisture, it is advisable to open the packaging just before use. During treatment with this medication, caution is advised for driving or operating hazardous machinery due to the risk of dizziness or fainting.

Serious side effects

Hives, severe swelling (including angioedema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, difficulty breathing or wheezing, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), severe malaise, sudden and very severe headache, thunderclap headache, seizures, confusion, visual disturbances.

Mild side effects

• Upper respiratory infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hypoglycemia

This medication should be stored in a tightly sealed container to protect it from air and moisture. Additionally, it is important to store it at room temperature between 1°C and 30°C to maintain its effectiveness.

Appearance

White oval tablet

Package unit

30 tablets/Alu-Alu [30 tablets/box (10 tablets/Alu-Alu x 3)], 30 tablets/bottle